New immuno-oncology therapies that direct the immune system to identify and destroy cancer cells have revolutionized cancer treatment.
Antibodies can increase the engagement of immune and tumor cells stimulating killing, by direct cytotoxicity or phagocytosis.
Cell engineering approaches to create T and NK cells to seek and destroy cancer offer vast potential, with the first of these cell-based therapies receiving regulatory approval.
Therefore, a deeper understanding of immune/tumor cell interactions and processes leading to cancer cell eradication is critical to identify and validate new targets and therapeutic approaches.
In this webinar Dr John O’Rourke will:
Complete the form below to access this webinar recording.